Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 7/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | SRC | P12931 | 2/20 | 0.84 |
| ▸ | APP | P05067 | 8/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.65 |
| ▸ | TTR | P02766 | 6/20 | 0.65 |
| ▸ | MAPT | P10636 | 5/20 | 0.65 |
| ▸ | HPGD | P15428 | 4/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.65 |
| ▸ | POLB | P06746 | 3/20 | 0.65 |
| ▸ | GAA | P10253 | 3/20 | 0.65 |
| ▸ | RECQL | P46063 | 2/20 | 0.65 |
| ▸ | MMP1 | P03956 | 2/20 | 0.65 |
| ▸ | THRB | P10828 | 2/20 | 0.65 |
| ▸ | APEX1 | P27695 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.65 |
| ▸ | LCK | P06239 | 2/20 | 0.65 |
| ▸ | FYN | P06241 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chicoric Acid SCHEMBL13772650 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL30518333 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL964775 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL30995918 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL730803 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Cichoric Acid SCHEMBL29385936 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL963407 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL961606 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Chicoric Acid SCHEMBL21176639 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC | |
| Cichoric Acid SCHEMBL15532218 | 1.00 | HSD17B10 (1.00) | HSD17B10TDP1ALOX15TP53SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4701437-A2 | PHARMACEUTICAL COMPOSITION TO SUPPORT THE IMMUNE SYSTEM BEFORE AND DURING UPPER RESPIRATORY TRACT INFECTIONS | Aronpharma SP. Z O. O (PL) | 2026-03-04 | — | — | EP | claimed |
| EP-2603098-B1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED (US) | 2025-08-06 | — | — | EP | claimed |
| US-20250009892-A1 | DELIVERY SYSTEMS AND METHODS FOR REACTIVE HYDROXYL-CONTAINING COMPOUNDS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2025-01-09 | — | — | US | claimed |
| WO-2024225922-A2 | PHARMACEUTICAL COMPOSITION TO SUPPORT THE IMMUNE SYSTEM BEFORE AND DURING UPPER RESPIRATORY TRACT INFECTIONS | ARONPHARMA SP. Z O. O. (PL) | 2024-10-31 | — | — | WO | claimed |
| US-20240309410-A1 | AN ENZYMATIC PROCESS FOR PRODUCING HYDROXYCINNAMIC ACID AMIDES (HCAA) | ANALYTICON DISCOVERY GMBH (DE) | 2024-09-19 | — | — | US | claimed |
| EP-4431611-A1 | AN ENZYMATIC PROCESS FOR PRODUCING HYDROXYCINNAMIC ACID AMIDES (HCAA) | Analyticon Discovery GmbH (DE) | 2024-09-18 | — | — | EP | claimed |
| EP-3823464-B1 | METHOD FOR REMOVING IMPURITIES FROM VEGETABLE PREPARATIONS | FRUTAROM SCHWEIZ AG (CH) | 2024-08-14 | — | — | EP | claimed |
| CN-113845422-B | Process for preparing L-chicoric acid from Echinacea purpurea in batches and application thereof | 山东中医药大学 | 2024-01-30 | — | — | CN | claimed |
| US-11732136-B2 | Hydroxycinnamic acid-derived crosslinkers | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2023-08-22 | — | — | US | claimed |
| US-11701400-B2 | Steviol glycoside compositions with reduced surface tension | CARGILL, INCORPORATED (US) | 2023-07-18 | — | — | US | claimed |
| US-11571407-B2 | Bicalutamide analogs or (S)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis | BCN PEPTIDES, S.A. (ES) | 2023-02-07 | — | — | US | claimed |
| WO-2023273955-A1 | METHOD FOR PREPARING NANOFIBER MEMBRANE COMPOSITE FABRIC | 南通大学 | 2023-01-05 | — | — | WO | claimed |
| US-20220242809-A1 | METHODS FOR ISOLATING ESSENTIAL OILS, PHYTOCHEMICALS AND PHARMACEUTICALLY ACTIVE COMPONENTS FROM BIOMASS AND RECONSTITUTING SYNTHETIC FORMULATIONS COMPRISING SAME | ATLAS HEMP COMPANY LLC (US) | 2022-08-04 | — | — | US | claimed |
| WO-2022153155-A1 | HYDROXYCINNAMIC ACID-DERIVED CROSSLINKING DIMERS | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2022-07-21 | — | — | WO | claimed |
| WO-2022153156-A1 | HYDROXYCINNAMIC ACID-DERIVED CROSSLINKERS | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2022-07-21 | — | — | WO | claimed |
| US-20220220280-A1 | HYDROXYCINNAMIC ACID-DERIVED CROSSLINKING DIMERS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2022-07-14 | — | — | US | claimed |
| US-20220220310-A1 | HYDROXYCINNAMIC ACID-DERIVED CROSSLINKERS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2022-07-14 | — | — | US | claimed |
| WO-2022141375-A1 | COMPOSITION FOR CARING FOR KERTATIN MATERIALS | L'OREAL (FR) | 2022-07-07 | — | — | WO | claimed |
| US-11261477-B2 | Glycosylation modification of bioactive compounds and drugs by plant glycosyltransferases (UGTs) | UNIVERSITY OF NORTH TEXAS (US) | 2022-03-01 | — | — | US | claimed |
| EP-3941188-A1 | PHYTOCOMPLEX AND EXTRACT OF A MERISTEMATIC CELL LINE SELECTED FROM ECHINACEA PURPUREA | Aethera Biotech S.r.l. (IT) | 2022-01-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11571407-B2 | Bicalutamide analogs or (S)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis | GBA1, GAA, GBA3 | HSD17B10 1472/4885TDP1 876/4885ALOX15 4056/4885 |
| US-11701400-B2 | Steviol glycoside compositions with reduced surface tension | STT3A, SIGLEC7, STT3B | HSD17B10 473/4885TDP1 1789/4885ALOX15 4388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.